DUBLIN–(BUSINESS WIRE)–The “Generic Oncology Sterile Injectable Market: Global Market Size, Forecast, Insights, and Competitive Landscape” report has been added to ResearchAndMarkets.com’s offering.
The global generic oncology sterile injectable market is expected to grow at a CAGR of around 11.3% during 2021-2027.
This report on global generic oncology sterile injectable market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape.
The report presents a clear picture of the global generic oncology sterile injectable market by segmenting the market based on size, product type, disease indication, distribution channel, and region. Also, detailed profiles of companies operating in the generic oncology sterile injectable market are provided in this report.
Historical & Forecast Period
- Base Year: 2020
- Historical Period: 2016-2019
- Forecast Period: 2021-2027
Market Dynamics
Drivers
- Increasing Launches of Drugs
- Rising Prevalence of Cancer
Challenges
- Stringent Rules and Regulations for Manufacturing
- High Operational Costs
Market by Product Type
- Chemotherapy
- Alkylating Agents
- Antimetabolites
- Plant Alkaloids
- Antitumor Antibiotics
- Others
- Monoclonal Antibodies
- Cytokines
- Peptide Hormones
Market by Disease Indication
- Ovarian Cancer
- Breast Cancer
- Lung Cancer
- Pancreatic Cancer
- Others
Market by Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Market by Region
- Europe
- Germany
- United Kingdom
- France
- Italy
- Spain
- Russia
- Netherlands
- Rest of Europe
- North America
- United States
- Canada
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Rest of Asia Pacific
- Latin America
- Mexico
- Brazil
- Argentina
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- Turkey
- Iran
- United Arab Emirates
- Rest of Middle East & Africa
Companies Mentioned
- Baxter International Inc.
- Biocon Ltd.
- Eli Lilly & Company
- Hikma Pharmaceuticals PLC
- Mylan N.V.
- Pfizer Inc.
- Sandoz International GmbH
- Teva Pharmaceutical Industries Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/veo16w.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900